Cardiol Therapeutics Announces Formation of Data Safety Monitoring and Clinical Endpoint Committees for Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19
The Pharma Data
JANUARY 20, 2021
Dr. Rouleau has an international reputation in cardiovascular research, particularly in the field of both basic mechanisms and improving the clinical care of patients with heart failure. He has been an Investigator in over 240 research projects with research funding exceeding $120 million.
Let's personalize your content